Fortis Healthcare Limited — Q3 FY26
Fortis Healthcare delivered a strong Q3 FY26 with consolidated revenue of INR 2,265 crore (+17.5% YoY) and EBITDA margin expansion of 290 bps to 22.3%, driven by hospital busine...
bullish
high
✓ Verified against BSE filing
Indian management teams deliver on roughly 12% of specific earnings-call promises. A low score does not indicate dishonesty — it reflects how aspirational forward guidance typically is.
Q2 FY26
Hospital EBITDA margin to exceed initial guidance of 20.5-22.5%
Management indicated possibility of higher margin improvement than guided at the beginning of the year, driven by ramp-up of new units.
Missed
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
heuristic_v1
Q2 FY26
ARPOB growth of 5-6% in H2 FY26
Management expects ARPOB growth of 5-6% in second half, driven by mix improvement and robotic surgeries.
Missed
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
heuristic_v1